The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is ...

In March 2023, the US Food and Drug Administration approved Acadia's Daybue (trofinetide) for treating Rett syndrome in ...

The FDA has narrowly beaten the European Medicines Agency (EMA) to the most approved drugs with a new active substance in ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZeneca’s position in the market.

Charles River and Akron Bio have announced the integration of the latter’s CSS liquid cytokines into the former's Cell ...

The CDE of China's NMPA has granted BTD to Innovent Biologics' IBI343 as a monotherapy treatment for CLDN18.2-positive PDAC ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

VK-2735 may be the first oral GLP-1R to gain approval in obesity. Credit: zimmytws via Shutterstock. Drugs targeting the glucagon-like peptide-1 receptor (GLP-1R) demonstrated remarkable success in ...

The radiopharmaceutical developer expanded its reach, acquiring R&D, isotope production, manufacturing, and distribution.

The European Commission granted an approval under exceptional circumstances to InflaRx’s immunosuppressant. The European ...

The metaverse hype is over, but developer Cassette Group has been working with Pfizer to realise its forgotten potential.